We are delighted to share our latest Singer Growth Economy Report on AI-enabled Drug Discovery under the Singer Growth Economy theme ‘Health & Wellbeing of the Population’, which focuses specifically on the growth driver ‘Efficiency through the Cycle, from Discovery to Consumer’.
In this latest report, we cover the evolution and application of AI in drug discovery, explore the industry landscape worldwide (incl. the global market & geographical presence), as well as examining the UK-based players both in the public and private space. Companies covered in this report include: Benevolent AI, Exscientia AI, LungLife AI, e-Therapeutics, Renalytix, C4X Discovery, Poolbeg Pharma and Spectral MD Holding.
Let’s Talk
If you’re looking for more information about any of our services, or if you can’t find what you’re looking for directly on our site, please do not hesitate to contact us.
